FFO
PBYI icon

Fortitude Family Office’s Puma Biotechnology PBYI Stock Holding History

Fortitude Family Office’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.1K Buy
+514
New +$4.52K ﹤0.01% 1547

Other funds holding PBYI

B
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return

Fortitude Family Office's PBYI Position: Q3 2026 in Review

Fortitude Family Office opened a new position in Puma Biotechnology (PBYI) in Q3 2026: 514 shares worth $5.1K. The stake represents ﹤0.01% of the portfolio and ranks #1547 among its holdings.

9 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.

  • Fortitude Family Office held 514 shares of Puma Biotechnology worth $5.1K as of Q3 2026.
  • Puma Biotechnology was a new Fortitude Family Office position in Q3 2026.
  • Puma Biotechnology made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #1547 holding.
  • 9 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.